APPLIED DNA SCIENCES INC (APDN) Stock Price & Overview
NASDAQ:APDN • US03815U6073
Current stock price
The current stock price of APDN is 5.62 USD. Today APDN is up by 31.62%. In the past month the price increased by 142.24%. In the past year, price decreased by -97.62%.
APDN Key Statistics
- Market Cap
- 7.25M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -924.25
- Dividend Yield
- N/A
APDN Stock Performance
APDN Stock Chart
APDN Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to APDN. When comparing the yearly performance of all stocks, APDN is a bad performer in the overall market: 95.84% of all stocks are doing better.
APDN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to APDN. APDN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
APDN Earnings
On August 14, 2025 APDN reported an EPS of -34 and a revenue of 304.39K. The company beat EPS expectations (11.11% surprise) and missed revenue expectations (-76.62% surprise).
APDN Forecast & Estimates
For the next year, analysts expect an EPS growth of 92.97% and a revenue growth 50.26% for APDN
APDN Groups
Sector & Classification
APDN Financial Highlights
Over the last trailing twelve months APDN reported a non-GAAP Earnings per Share(EPS) of -924.25. The EPS increased by 89.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -679.56% | ||
| ROE | -929.59% | ||
| Debt/Equity | 0 |
APDN Ownership
APDN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.13 | 174.674B | ||
| DHR | DANAHER CORP | 22.3 | 134.434B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 124.29 | 41.625B | ||
| A | AGILENT TECHNOLOGIES INC | 16.63 | 31.592B | ||
| WAT | WATERS CORP | 20.58 | 29.388B | ||
| IQV | IQVIA HOLDINGS INC | 12.96 | 27.945B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 25.68 | 24.203B | ||
| ILMN | ILLUMINA INC | 23.76 | 19.356B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.26 | 17.309B | ||
| MEDP | MEDPACE HOLDINGS INC | 25.96 | 13.081B | ||
| RVTY | REVVITY INC | 15.59 | 9.588B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.713B | ||
| TECH | BIO-TECHNE CORP | 23.14 | 8.071B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About APDN
Company Profile
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The firm is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The firm operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Company Info
IPO: 2001-08-24
APPLIED DNA SCIENCES INC
50 Health Sciences Drive
Stony Brook NEW YORK 11790 US
CEO: James A. Hayward
Employees: 47
Phone: 16312408800
APPLIED DNA SCIENCES INC / APDN FAQ
Can you describe the business of APPLIED DNA SCIENCES INC?
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The firm is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The firm operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
What is the stock price of APPLIED DNA SCIENCES INC today?
The current stock price of APDN is 5.62 USD. The price increased by 31.62% in the last trading session.
What is the dividend status of APPLIED DNA SCIENCES INC?
APDN does not pay a dividend.
What is the ChartMill rating of APPLIED DNA SCIENCES INC stock?
APDN has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the PE ratio for APDN stock?
APPLIED DNA SCIENCES INC (APDN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-924.25).
Can you provide the upcoming earnings date for APPLIED DNA SCIENCES INC?
APPLIED DNA SCIENCES INC (APDN) will report earnings on 2025-12-15, after the market close.